Ebaa Al Ozairi Real-world data from the Dasman Diabetes Institute in Kuwait published in Diabetes, Obesity and Metabolism examined changes in body weight, HbA1c and other cardiometabolic factors for adults with overweight and type 1 diabetes who were prescribed liraglutide (Saxenda/Victoza, Novo Nordisk), semaglutide (Ozempic/Wegovy, Novo Nordisk) and tirzepatide (Mounjaro/Zepbound, Eli Lilly)
L-carnitine food supplements are not intended to replace professional medical advice
Biohacking and wellness peptides like BPC-157 are everywherebut whats fact and whats fiction
Pre-exercise blood glucose below 100 mg/dL should prompt a snack before activity
No human clinical trials have been published
Our Approach to GLP-1 Medication At Chattahoochee Institute, we believe that meaningful, lasting health improvements begin with diet, exercise, and lifestyle changes